Want to see HK:1345 full AI Analyst Report?
Shanghai Pioneer Holding Ltd (1345) AI Stock Analysis
Shanghai Pioneer Holding Ltd
(HKEX:1345)
The overall score is driven primarily by solid profitability and a conservative balance sheet, tempered by slowing growth and uneven cash flow. Attractive yield and a reasonable P/E further support the stock, while technicals indicate stable but only modestly favorable trading momentum.
Shanghai Pioneer Holding Ltd (1345) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 2.26B
- Dividend Yield
- 6.15%
- Average Volume (3M)
- 422.03K
- Price to Earnings (P/E)
- 15.4
- Beta (1Y)
- 0.13
- Revenue Growth
- -5.80%
- EPS Growth
- 22.06%
- Country
- Hong Kong
- Employees
- 448
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Shanghai Pioneer Holding Ltd Business Overview & Revenue Model
Company Description
China Pioneer Pharma Holdings Limited operates as an investment holding company, primarily focusing on the marketing, promotion, and distribution of pharmaceutical goods and medical devices within mainland China. The firm maintains an extensive portf...
Shanghai Pioneer Holding Ltd Financial Statement Overview
Summary
Solid profitability and conservative leverage with strong margins and double-digit ROE, offset by slowing revenue and earnings growth and volatile cash generation.
Income Statement
70PositiveBalance Sheet
75PositiveCash Flow
62Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.24B | 1.28B | 1.53B | 1.57B | 1.56B | 1.43B |
| Gross Profit | 641.49M | 627.14M | 683.21M | 668.24M | 780.47M | 772.03M |
| EBITDA | 163.52M | 173.84M | 217.45M | 201.88M | 245.82M | 200.18M |
| Net Income | 123.05M | 114.38M | 151.62M | 145.72M | 235.30M | 142.63M |
Balance Sheet | ||||||
| Total Assets | 1.61B | 1.49B | 1.46B | 1.53B | 1.57B | 1.33B |
| Cash, Cash Equivalents and Short-Term Investments | 159.15M | 210.74M | 103.57M | 124.43M | 289.01M | 402.08M |
| Total Debt | 218.01M | 121.44M | 75.22M | 74.02M | 37.59M | 14.05M |
| Total Liabilities | 573.32M | 444.47M | 342.52M | 513.14M | 549.18M | 417.49M |
| Stockholders Equity | 1.04B | 1.05B | 1.11B | 1.01B | 1.01B | 907.97M |
Cash Flow | ||||||
| Free Cash Flow | 216.46M | 188.74M | 208.01M | -163.24M | 19.02M | 225.43M |
| Operating Cash Flow | 231.35M | 215.27M | 214.83M | -118.69M | 93.30M | 242.06M |
| Investing Cash Flow | -205.52M | -75.62M | -99.76M | 69.51M | -12.99M | 8.39M |
| Financing Cash Flow | -23.73M | -61.11M | -125.92M | -50.56M | -91.03M | -140.28M |
Shanghai Pioneer Holding Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1345, the sentiment is Negative. The current price of 1.95 is below the 20-day moving average (MA) of 2.04, below the 50-day MA of 2.13, and below the 200-day MA of 2.21, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 28.73 is Positive, neither overbought nor oversold. The STOCH value of 29.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1345.
Shanghai Pioneer Holding Ltd Peers Comparison
Overall Rating
HK:229177Outperform- HK:134571Outperform
HK:666961.6Neutral
HK:257654Neutral
HK:999648Neutral
HK:216043Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2291 | 77Outperform | HKD 4.51B | 18.87 | 10.01% | 4.35% | -4.20% | -25.57% |
| HK:1345 | 71Outperform | HKD 2.34B | 15.45 | 11.78% | 6.15% | -5.80% | 22.06% |
| HK:6669 | 62Neutral | HKD 1.64B | -27.72 | -3.50% | ― | 9.36% | -153.54% |
| HK:2576 | 54Neutral | HKD 2.33B | -30.39 | -5.91% | ― | ― | ― |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:9996 | 48Neutral | HKD 2.55B | -15.11 | -7.65% | ― | 21.23% | 36.89% |
| HK:2160 | 43Neutral | HKD 1.63B | -0.86 | -6.69% | ― | ― | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1345 | Shanghai Pioneer Holding Ltd | 1.95 | -0.01 | -0.56% | |
| HK:9996 | Peijia Medical Ltd. | 3.77 | -2.22 | -37.06% | |
| HK:6669 | Acotec Scientific Holdings Limited | 5.22 | -6.87 | -56.82% | |
| HK:2160 | MicroPort CardioFlow Medtech Corp. | 1.28 | -4.67 | -78.49% | |
| HK:2291 | LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H | 13.15 | -5.35 | -28.94% | |
| HK:2576 | Zhejiang Taimei Medical Technology Co Ltd Class H | 4.14 | -0.28 | -6.33% |
Shanghai Pioneer Holding Ltd Corporate Events
Shanghai Pioneer Holding Declares Interim Cash Dividend of HKD 0.056 Per Share
Shanghai Pioneer Holding Ltd has declared an interim ordinary cash dividend of HKD 0.056 per share for the six months ended 30 June 2026, payable in Hong Kong dollars to shareholders on the company’s register. The announcement underscores the b...
Shanghai Pioneer Lifts Interim Profit Despite Revenue Decline
Shanghai Pioneer Holding Ltd reported interim unaudited results for the six months ended 30 June 2026 showing a mixed top‑line and bottom‑line performance. Revenue declined 6.9% year on year to RMB602.8 million, but the Group maintained a...
Shanghai Pioneer Board to Review Interim Results and Consider Dividend
Shanghai Pioneer Holding Ltd has announced that its board of directors will convene on 28 August 2026 to review and approve the company’s interim results for the six months ended 30 June 2026. The meeting will also consider the publication of t...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026